IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v18y2021i9p4915-d549008.html
   My bibliography  Save this article

Significantly Reduced Alanine Aminotransferase Level Increases All-Cause Mortality Rate in the Elderly after Ischemic Stroke

Author

Listed:
  • Sang Joon An

    (Department of Neurology, Catholic Kwandong University International St Mary’s Hospital, Incheon 22711, Korea
    Sang Joon An and Yun-Jung Yang contributed equally to this work.)

  • Yun-Jung Yang

    (Institute of Biomedical Science, Catholic Kwandong University International St. Mary’s Hospital, Incheon 22711, Korea
    Sang Joon An and Yun-Jung Yang contributed equally to this work.)

  • Na-mo Jeon

    (Department of Rehabilitation Medicine, Catholic Kwandong University International St Mary’s Hospital, Incheon 22711, Korea)

  • Yeon-Pyo Hong

    (Department of Preventive Medicine, College of Medicine, Chung-Ang University, Seoul 06974, Korea)

  • Yeong In Kim

    (Department of Neurology, Catholic Kwandong University International St Mary’s Hospital, Incheon 22711, Korea)

  • Doo-Young Kim

    (Department of Rehabilitation Medicine, Catholic Kwandong University International St Mary’s Hospital, Incheon 22711, Korea)

Abstract

(1) Background: A significantly reduced alanine aminotransferase (ALT) level is being recognized as a risk factor of increasing mortality in the elderly in relation to frailty. In the elderly, both frailty and ischemic stroke are not only common, but are also associated with mortality. The aim of this research was to investigate whether a significantly reduced ALT level increases the all-cause mortality rate in the elderly with ischemic stroke. (2) Methods: Between February 2014 and April 2019, a retrospective study of 901 patients with ischemic stroke admitted to a university-affiliated hospital was conducted. Cox proportional hazard regression was used to determine whether a significantly reduced ALT level is an independent risk factor for mortality in elderly patients after an ischemic stroke. (3) Results: This study enrolled 323 older adults (age ≥ 65 years) who were first diagnosed with ischemic stroke. The mean age of the participants was 76.5 ± 6.6 years, the mean survival time was 37.1 ± 20.4 months, and the number of deaths was 96 (29.7%). Our results showed that reduced ALT level (less than 10 U/L) increased the risk of all-cause mortality in the elderly after ischemic stroke (adjusted HR: 3.24, 95% CI: 1.95–5.41; p < 0.001). (4) Conclusions: A significantly reduced ALT level at the time of diagnosis (less than 10 U/L) is an independent risk factor that increases the mortality rate in the elderly after ischemic stroke.

Suggested Citation

  • Sang Joon An & Yun-Jung Yang & Na-mo Jeon & Yeon-Pyo Hong & Yeong In Kim & Doo-Young Kim, 2021. "Significantly Reduced Alanine Aminotransferase Level Increases All-Cause Mortality Rate in the Elderly after Ischemic Stroke," IJERPH, MDPI, vol. 18(9), pages 1-10, May.
    • Handle: RePEc:gam:jijerp:v:18:y:2021:i:9:p:4915-:d:549008
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/18/9/4915/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/18/9/4915/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Zhengtao Liu & Huaijun Ning & Shuping Que & Linlin Wang & Xue Qin & Tao Peng, 2014. "Complex Association between Alanine Aminotransferase Activity and Mortality in General Population: A Systematic Review and Meta-Analysis of Prospective Studies," PLOS ONE, Public Library of Science, vol. 9(3), pages 1-19, March.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.

      More about this item

      Keywords

      ;
      ;
      ;
      ;
      ;

      Statistics

      Access and download statistics

      Corrections

      All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:9:p:4915-:d:549008. See general information about how to correct material in RePEc.

      If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

      If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

      If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

      For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

      Please note that corrections may take a couple of weeks to filter through the various RePEc services.

      IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.